Betting big on drug discovery, UK’s OMass Therapeutics raises $100 mln
April 28 (Reuters) – Betting on a fresh formula for the arduous, expensive and failure-prone field of drug discovery, UK-based OMass Therapeutics on Thursday said it has raised $100 million…
MORERelated News
Native mass spectrometry: Drug discovery’s new kid on the block
July 26, 2022
Current drug discovery methods have limited success against certain drug targets and better approaches are needed. Professor Dame Carol Robinson’s...
Novel drug-discovery approach lands big backers
May 5, 2022
UK-based OMass Therapeutics is leaning on a proprietary form of native mass spectrometry to help develop small-molecule drugs for rare...
OMass Therapeutics: The 21st Century Vertex?
April 29, 2022
Originally spun out of Oxford University, biotech firm OMass Therapeutics today completed an impressive $100m series B round. CEO Ros...